Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The study will assess if administration of high-dose vitamin D and a commonly used prebiotic
(inulin) is effective to reduce gastrointestinal dysbiosis and to improve critical intestinal
functions in Cystic Fibrosis with the additive or synergistic effects of the combination of
vitamin D + inulin.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins